RecruitingNCT05169762
Feminizing Treatment in Transgender Women and Non-binary Persons
Feminizing Treatment in Transgender Women and Non-binary Persons BODY IDENTITY CLINIC - ESTROGEN
Sponsor
Odense University Hospital
Enrollment
100 participants
Start Date
Feb 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria1
- assigned male at birth and eligeble for gender affirming feminizing treatment
Exclusion Criteria2
- none
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERstandard treatment
starndard treatment for transgender women
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05169762
Related Trials
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
NCT070925271 location
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
NCT048382491 location
Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
NCT042543541 location
Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)
NCT060937241 location
Puberty Suppression and Cardiometabolic Health
NCT044823741 location